Patent ID: 7892761
Filing Date: 2011-02-22
Classification: G01N

Abstract:
1. A method of diagnosing stomach cancer in a subject, comprising: determining an expression level of one or more proteins in a serum sample from the subject, wherein the proteins are selected from the group consisting of Leucine-rich alpha-2-glycoprotein (LRG), Clusterin, Apolipoprotein A-IV, Transthyretin, and ProApolipoprotein A-I; comparing the expression level of said one or more proteins to expression level of said one or more proteins in a normal control serum sample; and diagnosing, the subject with stomach cancer if there is an increase in expression level of one or more of LRG, Clusterin, and ProApolipoprotein A-I as compared to the control serum sample, a decrease in expression level of one or more of Apoliprotein A-IV and Transthyretin as compared to the control serum sample, or any combination thereof.